(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA1B mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:736398 6480464 epigallocatechin gallate results in decreased expression of HSPA1B mRNA CTD PMID:18851785 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of HSPA1B mRNA CTD PMID:16908007 (S)-amphetamine increases expression ISO RGD:736399 6480464 Dextroamphetamine results in increased expression of HSPA1B mRNA CTD PMID:19194377 1,2-dimethylhydrazine increases expression ISO RGD:736399 6480464 1, 2-Dimethylhydrazine results in increased expression of HSPA1B mRNA CTD PMID:22206623 1-naphthyl isothiocyanate affects expression EXP 6480464 1-Naphthylisothiocyanate affects the expression of HSPA1B mRNA CTD PMID:20551477 17beta-estradiol increases expression ISO RGD:736398 6480464 Estradiol results in increased expression of HSPA1B mRNA CTD PMID:20106945 17beta-estradiol multiple interactions ISO RGD:736399 6480464 bisindolylmaleimide I inhibits the reaction [Estradiol results in increased expression of HSPA1B mRNA], fulvestrant inhibits the reaction [Estradiol results in increased expression of HSPA1B mRNA] CTD PMID:12927369 17beta-estradiol increases expression ISO RGD:736399 6480464 Estradiol results in increased expression of HSPA1B mRNA CTD PMID:12927369 1H-pyrazole increases expression ISO RGD:736399 6480464 pyrazole results in increased expression of HSPA1B mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO RGD:736398 6480464 2 more ... CTD PMID:20638727 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA1B mRNA, Tetrachlorodibenzodioxin results in decreased expression of HSPA1B protein CTD PMID:16548065 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA1B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736399 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA1B mRNA CTD PMID:18691609 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736399 6480464 [Tetrachlorodibenzodioxin co-treated with geranylgeranylacetone] results in increased expression of HSPA1B mRNA more ... CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736399 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA1B mRNA, Tetrachlorodibenzodioxin results in increased expression of HSPA1B protein CTD PMID:15034205 more ... 2,5-hexanedione increases expression EXP 6480464 2, 5-hexanedione results in increased expression of HSPA1B mRNA CTD PMID:16141653 2-hydroxyethyl methacrylate increases expression ISO RGD:736398 6480464 hydroxyethyl methacrylate results in increased expression of HSPA1B mRNA CTD PMID:30497689 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of HSPA1B mRNA CTD PMID:16141653 2-methylcholine affects expression ISO RGD:736398 6480464 beta-methylcholine affects the expression of HSPA1B mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of HSPA1B protein CTD PMID:29105552 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione increases expression ISO RGD:736399 6480464 bisindolylmaleimide I results in increased expression of HSPA1B mRNA CTD PMID:12927369 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:736399 6480464 bisindolylmaleimide I inhibits the reaction [Estradiol results in increased expression of HSPA1B mRNA], bisindolylmaleimide I promotes the reaction [bisphenol A results in increased expression of HSPA1B mRNA] CTD PMID:12927369 3-phenylprop-2-enal increases expression ISO RGD:736398 6480464 cinnamaldehyde results in increased expression of HSPA1B mRNA CTD PMID:17178418 4,4'-sulfonyldiphenol increases expression ISO RGD:736398 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of HSPA1B protein CTD PMID:34186270 4-hydroxynon-2-enal increases expression ISO RGD:736399 6480464 4-hydroxy-2-nonenal results in increased expression of HSPA1B mRNA CTD PMID:19191707 5-fluorouracil decreases expression ISO RGD:736398 6480464 Fluorouracil results in decreased expression of HSPA1B protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:736398 6480464 HSPA1B protein affects the susceptibility to Fluorouracil CTD PMID:15352031 acrolein multiple interactions ISO RGD:736398 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA1B mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HSPA1B mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:736399 6480464 Acrylamide results in increased expression of HSPA1B mRNA CTD PMID:35032568 acrylamide increases expression ISO RGD:736398 6480464 Acrylamide results in increased expression of HSPA1B mRNA CTD PMID:32763439 adefovir pivoxil decreases expression ISO RGD:736398 6480464 adefovir dipivoxil results in decreased expression of HSPA1B mRNA CTD PMID:25596134 aflatoxin B1 decreases expression ISO RGD:736399 6480464 Aflatoxin B1 results in decreased expression of HSPA1B mRNA CTD PMID:19770486 alpha-pinene multiple interactions ISO RGD:736398 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA1B mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HSPA1B mRNA CTD PMID:32699268 AM-251 decreases expression ISO RGD:736398 6480464 AM 251 results in decreased expression of HSPA1B mRNA CTD PMID:16500647 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HSPA1B mRNA CTD PMID:16483693 amphotericin B decreases expression ISO RGD:736398 6480464 Amphotericin B analog results in decreased expression of HSPA1B mRNA CTD PMID:28534445 antimycin A increases expression ISO RGD:736398 6480464 Antimycin A results in increased expression of HSPA1B mRNA CTD PMID:33512557 apigenin affects expression ISO RGD:736399 6480464 Apigenin affects the expression of HSPA1B mRNA CTD PMID:22359648 aristolochic acid A increases expression ISO RGD:736398 6480464 aristolochic acid I results in increased expression of HSPA1B protein CTD PMID:33212167 arsane multiple interactions ISO RGD:736399 6480464 [APOE protein affects the susceptibility to Arsenic] which results in increased expression of HSPA1B mRNA more ... CTD PMID:22719926 , PMID:9820195 arsane multiple interactions ISO RGD:736398 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HSPA1B mRNA CTD PMID:32525701 arsane affects methylation ISO RGD:736398 6480464 Arsenic affects the methylation of HSPA1B gene CTD PMID:25304211 arsane decreases expression ISO RGD:736398 6480464 Arsenic results in decreased expression of HSPA1B mRNA CTD PMID:16835338 arsane decreases expression ISO RGD:736399 6480464 Arsenic results in decreased expression of HSPA1B mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:736398 6480464 Arsenic results in decreased expression of HSPA1B mRNA CTD PMID:16835338 arsenic atom multiple interactions ISO RGD:736398 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HSPA1B mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:736398 6480464 Arsenic affects the methylation of HSPA1B gene CTD PMID:25304211 arsenic atom decreases expression ISO RGD:736399 6480464 Arsenic results in decreased expression of HSPA1B mRNA CTD PMID:19654921 arsenic atom multiple interactions ISO RGD:736399 6480464 [APOE protein affects the susceptibility to Arsenic] which results in increased expression of HSPA1B mRNA more ... CTD PMID:22719926 , PMID:9820195 arsenite(3-) multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [arsenite results in increased expression of HSPA1B protein], Glutathione inhibits the reaction [arsenite results in increased expression of HSPA1B protein] CTD PMID:15175009 arsenite(3-) multiple interactions ISO RGD:736398 6480464 arsenite promotes the reaction [G3BP1 protein binds to HSPA1B mRNA] CTD PMID:32406909 arsenite(3-) increases expression ISO RGD:736399 6480464 arsenite results in increased expression of HSPA1B mRNA, arsenite results in increased expression of HSPA1B protein CTD PMID:15894712 , PMID:20835880 arsenite(3-) multiple interactions ISO RGD:736399 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of HSPA1B mRNA more ... CTD PMID:15894712 , PMID:20835880 arsenite(3-) affects localization ISO RGD:736399 6480464 arsenite affects the localization of HSPA1B protein CTD PMID:20835880 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of HSPA1B protein CTD PMID:15175009 arsenite(3-) increases expression ISO RGD:736398 6480464 arsenite results in increased expression of HSPA1B mRNA CTD PMID:16132727 , PMID:32406909 arsenous acid increases expression ISO RGD:736398 6480464 Arsenic Trioxide results in increased expression of HSPA1B mRNA CTD PMID:19417148 more ... arsenous acid affects expression ISO RGD:736398 6480464 Arsenic Trioxide affects the expression of HSPA1B mRNA CTD PMID:17530438 arsenous acid affects response to substance ISO RGD:736398 6480464 HSPA1B protein affects the susceptibility to Arsenic Trioxide CTD PMID:19371599 atrazine decreases expression ISO RGD:736398 6480464 Atrazine results in decreased expression of HSPA1B mRNA CTD PMID:22378314 azetidinecarboxylic acid increases expression ISO RGD:736399 6480464 Azetidinecarboxylic Acid results in increased expression of HSPA1B mRNA CTD PMID:12085988 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA CTD PMID:33854195 Benoxacor increases expression ISO RGD:736399 6480464 benoxacor results in increased expression of HSPA1B mRNA CTD PMID:34850242 benzene decreases expression ISO RGD:736398 6480464 Benzene results in decreased expression of HSPA1B mRNA CTD PMID:19162166 benzene-1,2,4-triol increases expression ISO RGD:736398 6480464 hydroxyhydroquinone results in increased expression of HSPA1B mRNA CTD PMID:17572062 benzo[a]pyrene multiple interactions ISO RGD:736399 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of HSPA1B mRNA more ... CTD PMID:15034205 more ... benzo[a]pyrene affects methylation ISO RGD:736398 6480464 Benzo(a)pyrene affects the methylation of HSPA1B promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:736398 6480464 Benzo(a)pyrene metabolite results in increased expression of HSPA1B mRNA, Benzo(a)pyrene results in increased expression of HSPA1B mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:736399 6480464 Benzo(a)pyrene results in increased expression of HSPA1B mRNA CTD PMID:15034205 more ... benzo[a]pyrene decreases expression ISO RGD:736399 6480464 Benzo(a)pyrene results in decreased expression of HSPA1B mRNA CTD PMID:19770486 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:736398 6480464 7 more ... CTD PMID:20382639 beta-naphthoflavone increases expression ISO RGD:736398 6480464 beta-Naphthoflavone results in increased expression of HSPA1B mRNA CTD PMID:19737606 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736399 6480464 Diethylhexyl Phthalate results in increased expression of HSPA1B mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:736399 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of HSPA1B mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate affects expression ISO RGD:736399 6480464 Diethylhexyl Phthalate affects the expression of HSPA1B mRNA CTD PMID:19850644 , PMID:21318169 bisphenol A increases expression ISO RGD:736399 6480464 bisphenol A results in increased expression of HSPA1B mRNA CTD PMID:12927369 more ... bisphenol A multiple interactions ISO RGD:736398 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of HSPA1B gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:736398 6480464 bisphenol A affects the expression of HSPA1B mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HSPA1B mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:736398 6480464 bisphenol A results in decreased expression of HSPA1B mRNA, bisphenol A results in decreased expression of HSPA1B protein CTD PMID:24901218 , PMID:34186270 bisphenol A multiple interactions ISO RGD:736399 6480464 bisindolylmaleimide I promotes the reaction [bisphenol A results in increased expression of HSPA1B mRNA], fulvestrant inhibits the reaction [bisphenol A results in increased expression of HSPA1B mRNA] CTD PMID:12927369 Bisphenol B increases expression ISO RGD:736398 6480464 bisphenol B results in increased expression of HSPA1B protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:736398 6480464 bisphenol F results in increased expression of HSPA1B protein CTD PMID:34186270 bortezomib increases expression ISO RGD:736398 6480464 Bortezomib results in increased expression of HSPA1B mRNA CTD PMID:15509775 more ... bortezomib affects response to substance ISO RGD:736398 6480464 HSPA1B protein affects the susceptibility to Bortezomib CTD PMID:23874968 bortezomib decreases response to substance ISO RGD:736398 6480464 HSPA1B protein results in decreased susceptibility to Bortezomib CTD PMID:23874968 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of HSPA1B mRNA CTD PMID:32479839 cadmium atom increases expression ISO RGD:736399 6480464 Cadmium results in increased expression of HSPA1B mRNA CTD PMID:12653483 cadmium atom multiple interactions ISO RGD:736398 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA1B mRNA CTD PMID:31738976 cadmium atom increases expression ISO RGD:736398 6480464 Cadmium results in increased expression of HSPA1B mRNA CTD PMID:21172416 more ... cadmium atom multiple interactions ISO RGD:736399 6480464 HSF1 protein affects the reaction [Cadmium results in increased expression of HSPA1B protein] CTD PMID:16282982 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of HSPA1B mRNA CTD PMID:22110744 cadmium dichloride multiple interactions ISO RGD:736398 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA1B mRNA CTD PMID:31738976 cadmium dichloride increases expression ISO RGD:736398 6480464 Cadmium Chloride results in increased expression of HSPA1B mRNA, Cadmium Chloride results in increased expression of HSPA1B protein CTD PMID:10544156 , PMID:25596134 cadmium dichloride increases expression ISO RGD:736399 6480464 Cadmium Chloride results in increased expression of HSPA1B mRNA CTD PMID:12085988 more ... cadmium dichloride decreases expression ISO RGD:736399 6480464 Cadmium Chloride results in decreased expression of HSPA1B mRNA CTD PMID:15501611 cadmium dichloride multiple interactions ISO RGD:736399 6480464 LL Z1640-2 inhibits the reaction [Cadmium Chloride results in increased expression of HSPA1B mRNA] CTD PMID:15081267 caffeine decreases phosphorylation ISO RGD:736398 6480464 Caffeine results in decreased phosphorylation of HSPA1B protein CTD PMID:35688186 cannabidiol multiple interactions ISO RGD:736398 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of HSPA1B mRNA CTD PMID:26504004 cannabidiol increases expression ISO RGD:736398 6480464 Cannabidiol results in increased expression of HSPA1B mRNA CTD PMID:26504004 captan increases expression ISO RGD:736399 6480464 Captan results in increased expression of HSPA1B mRNA CTD PMID:31558096 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO RGD:736398 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of HSPA1B mRNA CTD PMID:16039398 carboplatin increases expression EXP 6480464 Carboplatin results in increased expression of HSPA1B mRNA CTD PMID:18172885 carnosine increases expression EXP 6480464 Carnosine results in increased expression of HSPA1B protein CTD PMID:16984587 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of HSPA1B mRNA CTD PMID:18500788 celastrol increases expression ISO RGD:736398 6480464 celastrol results in increased expression of HSPA1B mRNA CTD PMID:17010675 chloroacetaldehyde decreases expression ISO RGD:736398 6480464 chloroacetaldehyde results in decreased expression of HSPA1B mRNA CTD PMID:25596134 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of HSPA1B mRNA CTD PMID:30744511 chloropicrin increases expression ISO RGD:736398 6480464 chloropicrin results in increased expression of HSPA1B mRNA CTD PMID:26352163 , PMID:28476498 chloroprene increases expression ISO RGD:736399 6480464 Chloroprene results in increased expression of HSPA1B mRNA CTD PMID:23125180 chloroquine multiple interactions ISO RGD:736398 6480464 Chloroquine inhibits the reaction [CPG-oligonucleotide results in increased expression of HSPA1B protein] CTD PMID:17046822 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA CTD PMID:33854195 cidofovir anhydrous decreases expression ISO RGD:736398 6480464 Cidofovir results in decreased expression of HSPA1B mRNA CTD PMID:25596134 cisplatin multiple interactions ISO RGD:736398 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of HSPA1B mRNA, Cisplatin promotes the reaction [Piroxicam results in decreased expression of HSPA1B mRNA] CTD PMID:21858171 , PMID:27392435 cisplatin decreases expression ISO RGD:736398 6480464 Cisplatin results in decreased expression of HSPA1B mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:736398 6480464 Cisplatin results in increased expression of HSPA1B mRNA CTD PMID:19561079 , PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of HSPA1B mRNA CTD PMID:18172885 , PMID:22023808 cobalt dichloride increases expression ISO RGD:736398 6480464 cobaltous chloride results in increased expression of HSPA1B mRNA CTD PMID:19320972 more ... cocaine affects expression ISO RGD:736399 6480464 Cocaine affects the expression of HSPA1B mRNA CTD PMID:15681117 cocaine increases expression EXP 6480464 Cocaine results in increased expression of HSPA1B mRNA CTD PMID:27899881 copper atom increases expression EXP 6480464 Copper results in increased expression of HSPA1B mRNA CTD PMID:22465980 copper atom multiple interactions ISO RGD:736398 6480464 [Chelating Agents binds to Copper] which results in increased expression of HSPA1B mRNA more ... CTD PMID:24690739 more ... copper atom increases expression ISO RGD:736399 6480464 Copper results in increased expression of HSPA1B mRNA CTD PMID:16629173 copper(0) increases expression EXP 6480464 Copper results in increased expression of HSPA1B mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RGD:736398 6480464 [Chelating Agents binds to Copper] which results in increased expression of HSPA1B mRNA more ... CTD PMID:24690739 more ... copper(0) increases expression ISO RGD:736399 6480464 Copper results in increased expression of HSPA1B mRNA CTD PMID:16629173 copper(II) chloride increases expression ISO RGD:736398 6480464 cupric chloride results in increased expression of HSPA1B mRNA CTD PMID:17211630 coumarin increases expression EXP 6480464 coumarin results in increased expression of HSPA1B mRNA CTD PMID:18480146 crocidolite asbestos increases expression ISO RGD:736398 6480464 Asbestos, Crocidolite results in increased expression of HSPA1B mRNA CTD PMID:18687144 cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of HSPA1B mRNA CTD PMID:18246545 cyclophosphamide increases expression ISO RGD:736398 6480464 Cyclophosphamide metabolite results in increased expression of HSPA1B mRNA CTD PMID:24356939 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of HSPA1B mRNA CTD PMID:16141653 cyclosporin A decreases expression ISO RGD:736399 6480464 Cyclosporine results in decreased expression of HSPA1B mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:736398 6480464 Cyclosporine results in increased expression of HSPA1B mRNA CTD PMID:20106945 more ... deguelin increases expression ISO RGD:736398 6480464 deguelin results in increased expression of HSPA1B mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:736399 6480464 Dexamethasone results in increased expression of HSPA1B mRNA CTD PMID:17998272 dextran sulfate multiple interactions ISO RGD:736399 6480464 [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of HSPA1B mRNA CTD PMID:26271895 diarsenic trioxide increases expression ISO RGD:736398 6480464 Arsenic Trioxide results in increased expression of HSPA1B mRNA CTD PMID:19417148 more ... diarsenic trioxide affects expression ISO RGD:736398 6480464 Arsenic Trioxide affects the expression of HSPA1B mRNA CTD PMID:17530438 diarsenic trioxide affects response to substance ISO RGD:736398 6480464 HSPA1B protein affects the susceptibility to Arsenic Trioxide CTD PMID:19371599 diazinon increases expression ISO RGD:736398 6480464 Diazinon results in increased expression of HSPA1B mRNA CTD PMID:24356939 dichloroacetic acid decreases expression ISO RGD:736399 6480464 Dichloroacetic Acid results in decreased expression of HSPA1B mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:736399 6480464 Diclofenac results in increased expression of HSPA1B mRNA CTD PMID:26934552 dieldrin increases expression ISO RGD:736398 6480464 Dieldrin results in increased expression of HSPA1B mRNA CTD PMID:31068361 diethyl maleate increases expression ISO RGD:736398 6480464 diethyl maleate results in increased expression of HSPA1B mRNA CTD PMID:33545341 dimethylarsinic acid decreases expression ISO RGD:736399 6480464 Cacodylic Acid results in decreased expression of HSPA1B mRNA CTD PMID:17441966 dimethylarsinic acid multiple interactions ISO RGD:736399 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA, OGG1 protein inhibits the reaction [Cacodylic Acid results in decreased expression of HSPA1B mRNA] CTD PMID:17441966 , PMID:34876320 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of HSPA1B mRNA, Oxygen deficiency results in increased expression of HSPA1B protein CTD PMID:17706837 dioxygen multiple interactions ISO RGD:736399 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HSPA1B mRNA CTD PMID:19640911 dioxygen multiple interactions EXP 6480464 [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HSPA1B mRNA, [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HSPA1B mRNA CTD PMID:25322861 , PMID:33729688 dioxygen decreases expression ISO RGD:736398 6480464 Oxygen deficiency results in decreased expression of HSPA1B mRNA CTD PMID:25596134 , PMID:26516004 diquat increases expression ISO RGD:736398 6480464 Diquat results in increased expression of HSPA1B mRNA CTD PMID:21172416 disulfiram increases expression ISO RGD:736398 6480464 Disulfiram results in increased expression of HSPA1B mRNA CTD PMID:20566472 disulfiram multiple interactions ISO RGD:736398 6480464 [Disulfiram binds to Copper] which results in decreased expression of HSPA1B mRNA CTD PMID:24690739 doxorubicin decreases expression ISO RGD:736399 6480464 Doxorubicin results in decreased expression of HSPA1B mRNA CTD PMID:15033991 elesclomol multiple interactions ISO RGD:736398 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HSPA1B mRNA] CTD PMID:18723479 elesclomol increases expression ISO RGD:736398 6480464 elesclomol results in increased expression of HSPA1B mRNA CTD PMID:18723479 ethanol multiple interactions ISO RGD:736398 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HSPA1B mRNA CTD PMID:29432896 ethanol multiple interactions ISO RGD:736399 6480464 Ethanol affects the expression of and affects the splicing of HSPA1B mRNA CTD PMID:30319688 fenpyroximate increases expression ISO RGD:736398 6480464 fenpyroximate results in increased expression of HSPA1B mRNA CTD PMID:33512557 fluoranthene multiple interactions ISO RGD:736399 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA1B mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA1B mRNA] CTD PMID:28329830 folpet increases expression ISO RGD:736399 6480464 folpet results in increased expression of HSPA1B mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:736398 6480464 Formaldehyde results in increased expression of HSPA1B mRNA CTD PMID:20655997 fructose increases expression EXP 6480464 Fructose results in increased expression of HSPA1B mRNA CTD PMID:15150374 fulvestrant multiple interactions ISO RGD:736399 6480464 fulvestrant inhibits the reaction [bisphenol A results in increased expression of HSPA1B mRNA], fulvestrant inhibits the reaction [Estradiol results in increased expression of HSPA1B mRNA] CTD PMID:12927369 fulvestrant multiple interactions ISO RGD:736398 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of HSPA1B gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of HSPA1B mRNA CTD PMID:26194646 gedunin increases expression ISO RGD:736398 6480464 gedunin results in increased expression of HSPA1B mRNA CTD PMID:17010675 genistein increases expression EXP 6480464 Genistein results in increased expression of HSPA1B mRNA CTD PMID:17341692 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HSPA1B mRNA CTD PMID:18172885 , PMID:33387578 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [arsenite results in increased expression of HSPA1B protein] CTD PMID:15175009 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA CTD PMID:33854195 glyphosate increases expression ISO RGD:736398 6480464 glyphosate results in increased expression of HSPA1B mRNA CTD PMID:31295307 gold atom multiple interactions ISO RGD:736398 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1B mRNA CTD PMID:28433809 gold(0) multiple interactions ISO RGD:736398 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1B mRNA CTD PMID:28433809 hydrogen chloride affects response to substance EXP 6480464 HSPA1B protein affects the susceptibility to Hydrochloric Acid CTD PMID:15338365 hydrogen peroxide increases expression ISO RGD:736398 6480464 Hydrogen Peroxide results in increased expression of HSPA1B mRNA CTD PMID:12414654 , PMID:34581912 hydrogen peroxide increases expression ISO RGD:736399 6480464 Hydrogen Peroxide results in increased expression of HSPA1B mRNA, Hydrogen Peroxide results in increased expression of HSPA1B protein CTD PMID:12085988 hypochlorous acid increases expression ISO RGD:736399 6480464 Hypochlorous Acid results in increased expression of HSPA1B mRNA CTD PMID:19376150 ifosfamide increases expression ISO RGD:736398 6480464 Ifosfamide results in increased expression of HSPA1B mRNA CTD PMID:25596134 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA CTD PMID:33854195 ivermectin decreases expression ISO RGD:736398 6480464 Ivermectin results in decreased expression of HSPA1B protein CTD PMID:32959892 L-serine decreases expression ISO RGD:736398 6480464 Serine results in decreased expression of HSPA1B mRNA CTD PMID:29098664 lead diacetate affects expression ISO RGD:736399 6480464 lead acetate affects the expression of HSPA1B mRNA CTD PMID:21829687 leflunomide affects expression ISO RGD:736398 6480464 leflunomide affects the expression of HSPA1B mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:736398 6480464 licochalcone B results in increased expression of HSPA1B mRNA CTD PMID:33647349 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of HSPA1B mRNA CTD PMID:35283115 lithium atom increases expression EXP 6480464 Lithium results in increased expression of HSPA1B protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of HSPA1B protein CTD PMID:18296634 LY294002 multiple interactions ISO RGD:736399 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [CPG-oligonucleotide results in increased expression of HSPA1B protein] CTD PMID:17046822 mancozeb increases expression ISO RGD:736399 6480464 mancozeb results in increased expression of HSPA1B mRNA CTD PMID:36007320 maneb multiple interactions ISO RGD:736399 6480464 [Maneb co-treated with Paraquat] results in decreased expression of HSPA1B mRNA, Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of HSPA1B mRNA] CTD PMID:23963992 menadione increases expression ISO RGD:736398 6480464 Vitamin K 3 results in increased expression of HSPA1B mRNA CTD PMID:12414654 mercury atom affects response to substance ISO RGD:736398 6480464 HSPA1B gene polymorphism affects the susceptibility to Mercury CTD PMID:23330093 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of HSPA1B mRNA CTD PMID:16507785 mercury(0) affects response to substance ISO RGD:736398 6480464 HSPA1B gene polymorphism affects the susceptibility to Mercury CTD PMID:23330093 methotrexate decreases expression ISO RGD:736398 6480464 Methotrexate results in decreased expression of HSPA1B mRNA CTD PMID:17400583 methylarsonic acid multiple interactions ISO RGD:736399 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA CTD PMID:34876320 methylisothiazolinone increases expression ISO RGD:736398 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of HSPA1B mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:736398 6480464 methylmercuric chloride results in increased expression of HSPA1B mRNA CTD PMID:24356939 , PMID:28001369 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of HSPA1B mRNA CTD PMID:30744511 methylparaben increases expression ISO RGD:736398 6480464 methylparaben results in increased expression of HSPA1B mRNA CTD PMID:31745603 microcystin RR increases expression ISO RGD:736398 6480464 microcystin RR results in increased expression of HSPA1B protein CTD PMID:19111056 mono(2-ethylhexyl) phthalate increases expression ISO RGD:736398 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of HSPA1B mRNA CTD PMID:24356939 motexafin gadolinium multiple interactions ISO RGD:736398 6480464 motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPA1B mRNA], Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of HSPA1B mRNA] CTD PMID:16357179 motexafin gadolinium increases expression ISO RGD:736398 6480464 motexafin gadolinium results in increased expression of HSPA1B mRNA CTD PMID:16357179 N-acetyl-L-cysteine multiple interactions ISO RGD:736398 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of HSPA1B mRNA] CTD PMID:18723479 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [arsenite results in increased expression of HSPA1B protein] CTD PMID:15175009 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:736399 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of HSPA1B mRNA, benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of HSPA1B protein CTD PMID:15525353 , PMID:25566086 N-methylformamide affects expression ISO RGD:736399 6480464 methylformamide affects the expression of HSPA1B mRNA, methylformamide analog affects the expression of HSPA1B mRNA CTD PMID:17040096 N-nitrosodiethylamine increases expression ISO RGD:736398 6480464 Diethylnitrosamine results in increased expression of HSPA1B mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions ISO RGD:736399 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HSPA1B mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression ISO RGD:736399 6480464 Diethylnitrosamine results in increased expression of HSPA1B mRNA CTD PMID:17942915 naphthalene increases expression ISO RGD:736399 6480464 naphthalene results in increased expression of HSPA1B mRNA CTD PMID:18978301 nickel dichloride decreases expression ISO RGD:736398 6480464 nickel chloride results in decreased expression of HSPA1B mRNA CTD PMID:17312168 Niflumic acid affects expression ISO RGD:736399 6480464 Niflumic Acid affects the expression of HSPA1B protein CTD PMID:16184763 oleanolic acid increases expression ISO RGD:736399 6480464 Oleanolic Acid results in increased expression of HSPA1B mRNA CTD PMID:18706400 organoselenium compound multiple interactions ISO RGD:736398 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1B mRNA CTD PMID:25167922 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of HSPA1B mRNA CTD PMID:23665939 ozone increases expression ISO RGD:736399 6480464 Ozone results in increased expression of HSPA1B mRNA, Ozone results in increased expression of HSPA1B protein CTD PMID:20032013 , PMID:21543283 ozone multiple interactions ISO RGD:736398 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA1B mRNA more ... CTD PMID:32699268 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HSPA1B mRNA CTD PMID:17202762 , PMID:33387578 paracetamol increases expression ISO RGD:736398 6480464 Acetaminophen results in increased expression of HSPA1B mRNA CTD PMID:25704631 paracetamol affects expression ISO RGD:736399 6480464 Acetaminophen affects the expression of HSPA1B mRNA CTD PMID:15606129 paracetamol increases expression ISO RGD:736399 6480464 Acetaminophen results in increased expression of HSPA1B mRNA CTD PMID:11264010 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of HSPA1B mRNA CTD PMID:18246545 paraquat multiple interactions ISO RGD:736399 6480464 [Maneb co-treated with Paraquat] results in decreased expression of HSPA1B mRNA, Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of HSPA1B mRNA] CTD PMID:23963992 paraquat increases expression ISO RGD:736398 6480464 Paraquat results in increased expression of HSPA1B mRNA CTD PMID:34097952 parathion increases expression ISO RGD:736399 6480464 Parathion results in increased expression of HSPA1B mRNA CTD PMID:34813904 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of HSPA1B mRNA CTD PMID:19162173 , PMID:21318169 perfluorooctanoic acid multiple interactions ISO RGD:736399 6480464 [PPARA protein affects the susceptibility to perfluorooctanoic acid] which affects the expression of HSPA1B mRNA CTD PMID:21318169 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of HSPA1B mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:736399 6480464 Phenobarbital results in increased expression of HSPA1B mRNA CTD PMID:19270015 more ... phenobarbital multiple interactions ISO RGD:736399 6480464 NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of HSPA1B mRNA] CTD PMID:19850644 picoxystrobin increases expression ISO RGD:736398 6480464 picoxystrobin results in increased expression of HSPA1B mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:736399 6480464 pirinixic acid results in increased expression of HSPA1B mRNA CTD PMID:15375163 more ... pirinixic acid decreases expression ISO RGD:736399 6480464 pirinixic acid results in decreased expression of HSPA1B mRNA CTD PMID:17426115 pirinixic acid multiple interactions ISO RGD:736399 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of HSPA1B mRNA] more ... CTD PMID:19850644 more ... piroxicam multiple interactions ISO RGD:736398 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of HSPA1B mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:736398 6480464 Piroxicam results in decreased expression of HSPA1B mRNA CTD PMID:21858171 polaprezinc increases expression EXP 6480464 polaprezinc results in increased expression of HSPA1B protein CTD PMID:16984587 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:736399 6480464 Pregnenolone Carbonitrile results in decreased expression of HSPA1B mRNA CTD PMID:22698814 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:736399 6480464 NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in decreased expression of HSPA1B mRNA] CTD PMID:22698814 progesterone increases expression ISO RGD:736398 6480464 Progesterone results in increased expression of HSPA1B mRNA CTD PMID:18037150 progesterone affects expression ISO RGD:736399 6480464 Progesterone affects the expression of HSPA1B mRNA CTD PMID:17251523 propanil increases expression ISO RGD:736398 6480464 Propanil results in increased expression of HSPA1B mRNA CTD PMID:24356939 propiconazole increases expression ISO RGD:736399 6480464 propiconazole results in increased expression of HSPA1B mRNA CTD PMID:21278054 pyrimidifen increases expression ISO RGD:736398 6480464 pyrimidifen results in increased expression of HSPA1B mRNA CTD PMID:33512557 quercetin decreases expression ISO RGD:736398 6480464 Quercetin results in decreased expression of HSPA1B mRNA, Quercetin results in decreased expression of HSPA1B protein CTD PMID:15221776 more ... quercetin decreases phosphorylation ISO RGD:736398 6480464 Quercetin results in decreased phosphorylation of HSPA1B protein CTD PMID:35688186 quercetin decreases expression ISO RGD:736399 6480464 Quercetin results in decreased expression of HSPA1B mRNA CTD PMID:17349211 quercetin multiple interactions ISO RGD:736399 6480464 Quercetin inhibits the reaction [CPG-oligonucleotide results in increased expression of HSPA1B protein] CTD PMID:17046822 raloxifene multiple interactions ISO RGD:736398 6480464 ESR1 protein affects the reaction [Raloxifene Hydrochloride results in decreased expression of HSPA1B mRNA] CTD PMID:14699072 raloxifene affects expression ISO RGD:736398 6480464 Raloxifene Hydrochloride affects the expression of HSPA1B mRNA CTD PMID:14699072 resorcinol decreases expression ISO RGD:736398 6480464 resorcinol results in decreased expression of HSPA1B mRNA CTD PMID:22623647 resveratrol increases expression ISO RGD:736398 6480464 resveratrol results in increased expression of HSPA1B mRNA CTD PMID:17956190 resveratrol multiple interactions ISO RGD:736399 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of HSPA1B mRNA] CTD PMID:31298478 rotenone decreases expression ISO RGD:736398 6480464 Rotenone results in decreased expression of HSPA1B mRNA CTD PMID:29955902 SB 203580 multiple interactions ISO RGD:736399 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HSPA1B mRNA] CTD PMID:28329830 sertraline increases expression ISO RGD:736398 6480464 Sertraline results in increased expression of HSPA1B mRNA CTD PMID:24865413 silicon dioxide increases expression ISO RGD:736399 6480464 Silicon Dioxide results in increased expression of HSP70 protein CTD PMID:36075289 silver atom increases expression ISO RGD:736398 6480464 Silver results in increased expression of HSPA1B mRNA CTD PMID:26014281 , PMID:28959546 silver atom increases expression ISO RGD:736399 6480464 Silver results in increased expression of HSPA1B mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:736398 6480464 Silver results in increased expression of HSPA1B mRNA CTD PMID:26014281 , PMID:28959546 silver(0) increases expression ISO RGD:736399 6480464 Silver results in increased expression of HSPA1B mRNA CTD PMID:27131904 sinapic acid decreases expression ISO RGD:736399 6480464 sinapinic acid analog results in decreased expression of HSPA1B mRNA CTD PMID:36279966 sirolimus decreases expression ISO RGD:736398 6480464 Sirolimus results in decreased expression of HSPA1B mRNA CTD PMID:24356939 sodium arsenate multiple interactions ISO RGD:736398 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HSPA1B mRNA CTD PMID:32525701 sodium arsenate multiple interactions ISO RGD:736399 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:736399 6480464 sodium arsenite results in increased expression of HSPA1B mRNA, sodium arsenite results in increased expression of HSPA1B protein CTD PMID:11353140 more ... sodium arsenite multiple interactions ISO RGD:736399 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of HSPA1B mRNA CTD PMID:34876320 sodium arsenite affects methylation ISO RGD:736398 6480464 sodium arsenite affects the methylation of HSPA1B gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:736398 6480464 sodium arsenite results in increased expression of HSPA1B mRNA CTD PMID:10544156 more ... sodium chloride increases expression ISO RGD:736399 6480464 Sodium Chloride results in increased expression of HSPA1B mRNA, Sodium Chloride results in increased expression of HSPA1B protein CTD PMID:12085988 sodium dichromate decreases expression ISO RGD:736399 6480464 sodium bichromate results in decreased expression of HSPA1B mRNA CTD PMID:31558096 Sodium salicylate affects expression ISO RGD:736399 6480464 Sodium Salicylate affects the expression of HSPA1B protein CTD PMID:16184763 Soman increases expression EXP 6480464 Soman results in increased expression of HSPA1B mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:736399 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSPA1B mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HSPA1B mRNA CTD PMID:21641980 , PMID:26378955 sulfasalazine decreases expression EXP 6480464 Sulfasalazine results in decreased expression of HSPA1B mRNA CTD PMID:16141653 sulforaphane increases expression ISO RGD:736398 6480464 sulforaphane results in increased expression of HSPA1B mRNA CTD PMID:31838189 sulindac sulfide increases expression ISO RGD:736398 6480464 sulindac sulfide results in increased expression of HSPA1B mRNA CTD PMID:16184548 tamoxifen affects expression ISO RGD:736399 6480464 Tamoxifen affects the expression of HSPA1B mRNA CTD PMID:20937368 tanespimycin multiple interactions ISO RGD:736398 6480464 [tanespimycin co-treated with VER 155008] results in increased expression of HSPA1B protein CTD PMID:31370342 tebufenpyrad increases expression ISO RGD:736398 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of HSPA1B mRNA CTD PMID:33512557 temozolomide decreases expression ISO RGD:736398 6480464 Temozolomide results in decreased expression of HSPA1B mRNA CTD PMID:31758290 teprenone multiple interactions ISO RGD:736399 6480464 [Tetrachlorodibenzodioxin co-treated with geranylgeranylacetone] results in increased expression of HSPA1B mRNA, [Tetrachlorodibenzodioxin co-treated with geranylgeranylacetone] results in increased expression of HSPA1B protein CTD PMID:15340226 tert-butyl hydroperoxide increases expression ISO RGD:736398 6480464 tert-Butylhydroperoxide results in increased expression of HSPA1B mRNA CTD PMID:12414654 testosterone enanthate affects expression ISO RGD:736398 6480464 testosterone enanthate affects the expression of HSPA1B mRNA CTD PMID:17440010 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of HSPA1B protein CTD PMID:15338365 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA1B mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of HSPA1B mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:736399 6480464 Carbon Tetrachloride results in increased expression of HSPA1B mRNA CTD PMID:25270620 more ... thapsigargin decreases expression ISO RGD:736398 6480464 Thapsigargin results in decreased expression of HSPA1B mRNA CTD PMID:22378314 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA CTD PMID:33854195 thimerosal increases expression ISO RGD:736398 6480464 Thimerosal results in increased expression of HSPA1B mRNA CTD PMID:16870260 titanium dioxide decreases expression ISO RGD:736399 6480464 titanium dioxide results in decreased expression of HSPA1B mRNA CTD PMID:29128614 , PMID:29264374 titanium dioxide multiple interactions ISO RGD:736399 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of HSPA1B mRNA] CTD PMID:31298478 titanium dioxide increases expression ISO RGD:736399 6480464 titanium dioxide results in increased expression of HSPA1B mRNA CTD PMID:31298478 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of HSPA1B mRNA CTD PMID:30012374 triazines multiple interactions ISO RGD:736399 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of HSPA1B mRNA] CTD PMID:27469509 tributylstannane decreases expression ISO RGD:736399 6480464 tributyltin results in decreased expression of HSPA1B mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of HSPA1B mRNA CTD PMID:33387578 trichostatin A affects expression ISO RGD:736398 6480464 trichostatin A affects the expression of HSPA1B mRNA CTD PMID:28542535 Triptolide increases expression EXP 6480464 triptolide results in increased expression of HSPA1B protein CTD PMID:32519852 tunicamycin decreases expression ISO RGD:736399 6480464 Tunicamycin results in decreased expression of HSPA1B mRNA CTD PMID:17127020 tunicamycin decreases expression ISO RGD:736398 6480464 Tunicamycin results in decreased expression of HSPA1B mRNA CTD PMID:22378314 , PMID:29453283 urethane increases expression ISO RGD:736398 6480464 Urethane results in increased expression of HSPA1B mRNA CTD PMID:28818685 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HSPA1B mRNA CTD PMID:21318169 valproic acid increases expression ISO RGD:736398 6480464 Valproic Acid results in increased expression of HSPA1B mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:736399 6480464 Valproic Acid results in increased expression of HSPA1B mRNA CTD PMID:21427059 vanillin increases expression ISO RGD:736398 6480464 vanillin results in increased expression of HSPA1B mRNA CTD PMID:17178418 zearalenone increases expression ISO RGD:736398 6480464 Zearalenone results in increased expression of HSPA1B mRNA CTD PMID:25424538 zearalenone increases expression ISO RGD:736399 6480464 Zearalenone results in increased expression of HSPA1B mRNA CTD PMID:27862621 zinc acetate multiple interactions ISO RGD:736398 6480464 motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of HSPA1B mRNA], Zinc Acetate promotes the reaction [motexafin gadolinium results in increased expression of HSPA1B mRNA] CTD PMID:16357179 zinc acetate increases expression ISO RGD:736398 6480464 Zinc Acetate results in increased expression of HSPA1B mRNA CTD PMID:16357179 zinc atom affects abundance ISO RGD:736398 6480464 HSPA1B gene SNP affects the abundance of Zinc CTD PMID:16513158 zinc atom multiple interactions ISO RGD:736398 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPA1B mRNA CTD PMID:18593933 zinc dichloride increases expression ISO RGD:736399 6480464 zinc chloride results in increased expression of HSPA1B mRNA CTD PMID:12085988 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of HSPA1B protein CTD PMID:16984587 zinc sulfate increases expression ISO RGD:736398 6480464 Zinc Sulfate results in increased expression of HSPA1B mRNA CTD PMID:23274768 zinc(0) affects abundance ISO RGD:736398 6480464 HSPA1B gene SNP affects the abundance of Zinc CTD PMID:16513158 zinc(0) multiple interactions ISO RGD:736398 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of HSPA1B mRNA CTD PMID:18593933
